Dopamine promotes cellular iron accumulation and oxidative stress responses in macrophages

Biochemical Pharmacology

Volumn 148, Issue , 2018, Pages 193-201

  Dichtl, Stefanie ^a   Haschka, David ^a   Nairz, Manfred ^a   Seifert, Markus ^a   Volani, Chiara ^a   Lutz, Oliver ^b   Weiss, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b ADSI Austrian Drug Screening Institute   (Austria)

Author keywords

Catecholamine; Dopamine; Iron; Macrophage; Oxidative stress

Indexed keywords

DOPAMINE; FERROPORTIN 1; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IRON; NORADRENALIN; TRANSCRIPTION FACTOR NRF2; TYROSINE;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL LEVEL; CONTROLLED STUDY; GENE DELETION; GENETIC TRANSCRIPTION; IRON HOMEOSTASIS; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; KNOCKOUT MOUSE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DOPAMINE; GENE EXPRESSION REGULATION; IRON; MACROPHAGES; MICE; MICE, KNOCKOUT; NOREPINEPHRINE; OXIDATIVE STRESS; TYROSINE;

EID: 85040353411     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2017.12.001     Document Type: Article

References (56)

1. Hentze, M.W., Muckenthaler, M.U., Galy, B., Camaschella, C., Two to tango: regulation of Mammalian iron metabolism. Cell 142:1 (2010), 24–38.
2. Wang, J., Pantopoulos, K., Regulation of cellular iron metabolism. Biochem. J. 434:3 (2011), 365–381.
3. Macdougall, I.C., Canaud, B., de Francisco, A.L., Filippatos, G., Ponikowski, P., Silverberg, D., van Veldhuisen, D.J., Anker, S.D., Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency. Eur. J. Heart Fail. 14:8 (2012), 882–886.
4. Jankowska, E.A., Malyszko, J., Ardehali, H., Koc-Zorawska, E., Banasiak, W., von Haehling, S., Macdougall, I.C., Weiss, G., McMurray, J.J., Anker, S.D., Gheorghiade, M., Ponikowski, P., Iron status in patients with chronic heart failure. Eur. Heart J. 34:11 (2013), 827–834.
5. Oexle, H., Gnaiger, E., Weiss, G., Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim Biophys Acta 1413:3 (1999), 99–107.
6. Camaschella, C., Iron-deficiency anemia. N. Engl. J. Med. 372:19 (2015), 1832–1843.
7. Koskenkorva-Frank, T.S., Weiss, G., Koppenol, W.H., Burckhardt, S., The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic. Biol. Med. 65 (2013), 1174–1194.
8. Pietrangelo, A., Hereditary hemochromatosis–a new look at an old disease. N. Engl. J. Med. 350:23 (2004), 2383–2397.
9. Brissot, P., Troadec, M.B., Bardou-Jacquet, E., Le Lan, C., Jouanolle, A.M., Deugnier, Y., Loreal, O., Current approach to hemochromatosis. Blood Rev. 22:4 (2008), 195–210.
10. Pantopoulos, K., Porwal, S.K., Tartakoff, A., Devireddy, L., Mechanisms of mammalian iron homeostasis. Biochemistry 51:29 (2012), 5705–5724.
11. Liuzzi, J.P., Aydemir, F., Nam, H., Knutson, M.D., Cousins, R.J., Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc. Natl. Acad. Sci. USA 103:37 (2006), 13612–13617.
12. Lok, C.N., Ponka, P., Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 274:34 (1999), 24147–24152.
13. Tacchini, L., Bianchi, L., Bernelli-Zazzera, A., Cairo, G., Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 274:34 (1999), 24142–24146.
14. Sohn, Y.S., Mitterstiller, A.M., Breuer, W., Weiss, G., Cabantchik, Z.I., Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal. Br. J. Pharmacol. 164:2b (2011), 406–418.
15. Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., Ganz, T., Kaplan, J., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:5704 (2004), 2090–2093.
16. Muckenthaler, M.U., Galy, B., Hentze, M.W., Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 28 (2008), 197–213.
17. Bao, G., Clifton, M., Hoette, T.M., Mori, K., Deng, S.X., Qiu, A., Viltard, M., Williams, D., Paragas, N., Leete, T., Kulkarni, R., Li, X., Lee, B., Kalandadze, A., Ratner, A.J., Pizarro, J.C., Schmidt-Ott, K.M., Landry, D.W., Raymond, K.N., Strong, R.K., Barasch, J., Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat. Chem. Biol. 6:8 (2010), 602–609.
18. Devireddy, L.R., Hart, D.O., Goetz, D.H., Green, M.R., A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell 141:6 (2010), 1006–1017.
19. Chakraborty, S., Kaur, S., Guha, S., Batra, S.K., The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta 1826:1 (2012), 129–169.
20. Nairz, M., Theurl, I., Schroll, A., Theurl, M., Fritsche, G., Lindner, E., Seifert, M., Crouch, M.L., Hantke, K., Akira, S., Fang, F.C., Weiss, G., Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 114:17 (2009), 3642–3651.
21. Liu, Z., Reba, S., Chen, W.D., Porwal, S.K., Boom, W.H., Petersen, R.B., Rojas, R., Viswanathan, R., Devireddy, L., Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection. J. Exp. Med. 211:6 (2014), 1197–1213.
22. Gaeta, A., Hider, R.C., The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br. J. Pharmacol. 146:8 (2005), 1041–1059.
23. Nguyen, K.D., Qiu, Y., Cui, X., Goh, Y.P., Mwangi, J., David, T., Mukundan, L., Brombacher, F., Locksley, R.M., Chawla, A., Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480:7375 (2011), 104–108.
24. Josefsson, E., Bergquist, J., Ekman, R., Tarkowski, A., Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88:1 (1996), 140–146.
25. Spengler, R.N., Chensue, S.W., Giacherio, D.A., Blenk, N., Kunkel, S.L., Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J. Immunol. 152:6 (1994), 3024–3031.
26. Moreau, A., Le Vee, M., Jouan, E., Parmentier, Y., Fardel, O., Drug transporter expression in human macrophages. Fundam. Clin. Pharmacol. 25:6 (2011), 743–752.
27. Gether, U., Andersen, P.H., Larsson, O.M., Schousboe, A., Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol. Sci. 27:7 (2006), 375–383.
28. Stokes, A.H., Hastings, T.G., Vrana, K.E., Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 55:6 (1999), 659–665.
29. Loboda, A., Damulewicz, M., Pyza, E., Jozkowicz, A., Dulak, J., Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol. Life Sci. 73:17 (2016), 3221–3247.
30. Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A.M., Cook, J.L., Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274:37 (1999), 26071–26078.
31. Nairz, M., Schleicher, U., Schroll, A., Sonnweber, T., Theurl, I., Ludwiczek, S., Talasz, H., Brandacher, G., Moser, P.L., Muckenthaler, M.U., Fang, F.C., Bogdan, C., Weiss, G., Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J. Exp. Med. 210:5 (2013), 855–873.
32. Haschka, D., Nairz, M., Demetz, E., Wienerroither, S., Decker, T., Weiss, G., Contrasting regulation of macrophage iron homeostasis in response to infection with Listeria monocytogenes depending on localization of bacteria. Metallomics 7:6 (2015), 1036–1045.
33. Nairz, M., Theurl, I., Ludwiczek, S., Theurl, M., Mair, S.M., Fritsche, G., Weiss, G., The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol. 9:9 (2007), 2126–2140.
34. Theurl, I., Hilgendorf, I., Nairz, M., Tymoszuk, P., Haschka, D., Asshoff, M., He, S., Gerhardt, L.M., Holderried, T.A., Seifert, M., Sopper, S., Fenn, A.M., Anzai, A., Rattik, S., McAlpine, C., Theurl, M., Wieghofer, P., Iwamoto, Y., Weber, G.F., Harder, N.K., Chousterman, B.G., Arvedson, T.L., McKee, M., Wang, F., Lutz, O.M., Rezoagli, E., Babitt, J.L., Berra, L., Prinz, M., Nahrendorf, M., Weiss, G., Weissleder, R., Lin, H.Y., Swirski, F.K., On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat. Med. 22:8 (2016), 945–951.
35. Zhang, S., Chen, Y., Guo, W., Yuan, L., Zhang, D., Xu, Y., Nemeth, E., Ganz, T., Liu, S., Disordered hepcidin-ferroportin signaling promotes breast cancer growth. Cell Signal. 26:11 (2014), 2539–2550.
36. Volani, C., Doerrier, C., Demetz, E., Haschka, D., Paglia, G., Lavdas, A.A., Gnaiger, E., Weiss, G., Dietary iron loading negatively affects liver mitochondrial function. Metallomics 9:11 (2017), 1634–1644.
37. Gozzelino, R., Jeney, V., Soares, M.P., Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 50 (2010), 323–354.
38. Mitterstiller, A.M., Haschka, D., Dichtl, S., Nairz, M., Demetz, E., Talasz, H., Soares, M.P., Einwallner, E., Esterbauer, H., Fang, F.C., Geley, S., Weiss, G., Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection. Cell Microbiol. 18:10 (2016), 1374–1389.
39. Flo, T.H., Smith, K.D., Sato, S., Rodriguez, D.J., Holmes, M.A., Strong, R.K., Akira, S., Aderem, A., Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:7019 (2004), 917–921.
40. Anderson, C.P., Shen, M., Eisenstein, R.S., Leibold, E.A., Mammalian iron metabolism and its control by iron regulatory proteins. Biochim Biophys Acta 1823:9 (2012), 1468–1483.
41. Marro, S., Chiabrando, D., Messana, E., Stolte, J., Turco, E., Tolosano, E., Muckenthaler, M.U., Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter. Haematologica 95:8 (2010), 1261–1268.
42. Harada, N., Kanayama, M., Maruyama, A., Yoshida, A., Tazumi, K., Hosoya, T., Mimura, J., Toki, T., Maher, J.M., Yamamoto, M., Itoh, K., Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys 508:1 (2011), 101–109.
43. Wang, G.L., Semenza, G.L., Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82:12 (1993), 3610–3615.
44. Kim, Y.H., Coon, A., Baker, A.F., Powis, G., Antitumor agent PX-12 inhibits HIF-1alpha protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase. Cancer Chemother. Pharmacol. 68:2 (2011), 405–413.
45. Tarazi, F.I., Neuropharmacology of dopamine receptors: Implications in neuropsychiatric diseases. J. Sci. Res. Med. Sci. 3:2 (2001), 93–104.
46. Basu, S., Dasgupta, P.S., Dopamine, a neurotransmitter, influences the immune system. J. Neuroimmunol. 102:2 (2000), 113–124.
47. Zhang, H.Y., Wang, N.D., Song, N., Xu, H.M., Shi, L.M., Jiang, H., Xie, J.X., 6-Hydroxydopamine promotes iron traffic in primary cultured astrocytes. Biometals 26:5 (2013), 705–714.
48. Gammella, E., Buratti, P., Cairo, G., Recalcati, S., The transferrin receptor: the cellular iron gate. Metallomics 9:10 (2017), 1367–1375.
49. El Hage Chahine, J.M., Hemadi, M., Ha-Duong, N.T., Uptake and release of metal ions by transferrin and interaction with receptor 1. Biochim Biophys Acta 1820:3 (2012), 334–347.
50. Goetz, D.H., Holmes, M.A., Borregaard, N., Bluhm, M.E., Raymond, K.N., Strong, R.K., The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 10:5 (2002), 1033–1043.
51. Arreguin, S., Nelson, P., Padway, S., Shirazi, M., Pierpont, C., Dopamine complexes of iron in the etiology and pathogenesis of Parkinson's disease. J. Inorg. Biochem. 103:1 (2009), 87–93.
52. Melin, V., Henriquez, A., Freer, J., Contreras, D., Reactivity of catecholamine-driven Fenton reaction and its relationships with iron(III) speciation. Redox Rep. 20:2 (2015), 89–96.
53. Schmidt, J., Mertz, K., Morgan, J.I., Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes. Brain Res. Mol. Brain Res. 73:1–2 (1999), 50–59.
54. Hare, D.J., Double, K.L., Iron and dopamine: a toxic couple. Brain 139:Pt 4 (2016), 1026–1035.
55. Khan, F.H., Ahlberg, C.D., Chow, C.A., Shah, D.R., Koo, B.B., Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome. J. Neurol. 264:8 (2017), 1634–1641.
56. Jais, A., Einwallner, E., Sharif, O., Gossens, K., Lu, T.T., Soyal, S.M., Medgyesi, D., Neureiter, D., Paier-Pourani, J., Dalgaard, K., Duvigneau, J.C., Lindroos-Christensen, J., Zapf, T.C., Amann, S., Saluzzo, S., Jantscher, F., Stiedl, P., Todoric, J., Martins, R., Oberkofler, H., Muller, S., Hauser-Kronberger, C., Kenner, L., Casanova, E., Sutterluty-Fall, H., Bilban, M., Miller, K., Kozlov, A.V., Krempler, F., Knapp, S., Lumeng, C.N., Patsch, W., Wagner, O., Pospisilik, J.A., Esterbauer, H., Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man. Cell 158:1 (2014), 25–40.